EichorEICHOR
Location: Guildford Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Guildford

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

EU Post-Market Registry to Collect Real-World Clinical Data on the Use of the Histolog Scanner.
Phase N/A · Royal Surrey County Hospital NHS Foundation Trust · SamanTree Medical SA · NCT07006090A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in
Phase N/A · Royal Surrey County Hospital · Hoffmann-La Roche · NCT07284121Visugromab in Cachexia International Trial
Phase 2/Phase 3 · Royal Surrey County Hospital · CatalYm GmbH · NCT07112196Insect vs Animal Protein for Building Muscle
NA · University of Surrey, Stag Hill Campus · University of Surrey · NCT07159919A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancre
Phase 3 · Investigative Site GB011 · Incyte Corporation · NCT07522073The Remote Study: Investigating the Effects or Online Exercise on Quality of Life in Men With Prostate Cancer
NA · University of Surrey · University of Surrey · NCT05989854EUthyroid2: the Next Step Towards the Elimination of Iodine Deficiency and Preventable Iodine-related Disorders in Europ
NA · University of Surrey · EUthyroid · NCT06769009An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Phase 3 · Research Site · AstraZeneca · NCT05952557An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05939414Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
Phase 1/Phase 2 · Research Site · AstraZeneca · NCT07590934A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kid
Phase 2 · Research Site · AstraZeneca · NCT07215702Clinical and Immunogenetic Characterization of Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR)
Phase N/A · Royal Surrey County Hospital, Royal Surrey County Hospital N · University of Leeds · NCT04102930A Study to Provide Continued Access to and Assess Long-Term Safety of the Study Drug(s)
Phase 3 · Royal Surrey County Hospital · Daiichi Sankyo · NCT06174987Developing ctDNA Guided Adjuvant Therapy for Gastrooesophageal Cancer
Phase 2 · Royal Surrey NHS Foundation Trust, Royal Surrey County Hospi · University of Southampton · NCT05965479LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have C
Phase 3 · St Luke's Cancer Centre · Boehringer Ingelheim · NCT06632457Will a Pre-therapy Exercise Intervention Improve the Outcomes of Patients With Advanced Oesophageal Cancer?
NA · University of Surrey · University of Surrey · NCT07375420The Next Step Towards the Elimination of Iodine Deficiency and Preventable Iodine-related Disorders in Europe
NA · University of Surrey; Queen's University Belfast · EUthyroid · NCT06801691Palliative Care and Oncology Survey on Terminology
Phase N/A · Royal Surrey County Hospital · Our Lady's Hospice and Care Services · NCT05871996Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Phase 3 · Royal Surrey County Hospital · Nuvalent Inc. · NCT06765109A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurre
Phase 3 · Royal Surrey County Hospital NHS Trust · Janssen Research & Development, LLC · NCT07276399Drone Delivery of Automated External Defibrillators to Lay Users (DAEDALUS): A Proof of Concept Study
Phase N/A · University of Surrey · University of Surrey · NCT07430813Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Mon
Phase 3 · Royal Surrey County Hospital NHS Foundation Trust - St Lukes · ImmunityBio, Inc. · NCT06745908A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Particip
Phase 3 · Royal Surrey County Hospital · Bayer · NCT06452277A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combinat
Phase 2/Phase 3 · Local Institution - 0644 · Bristol-Myers Squibb · NCT07221357Vitamin D and Health Status of British African-Caribbean Women
Phase N/A · University of Surrey · University of Surrey · NCT04179370A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With
Phase 3 · Investigational Site Number : 8260006 · Sanofi · NCT07088068Exercise to Improve Outcomes in Pancreatic Cancer
NA · University of Surrey · University of Surrey · NCT07710495Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy o
Phase 3 · Research Site · AstraZeneca · NCT06380751A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet
Phase 2 · Local Institution - 0037 · Bristol-Myers Squibb · NCT07680764
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.